Skip to menu Skip to content Skip to footer

Human Leukaemia Inhibitory Factor (hLIF): A Potential Anti-Atherosclerotic/Anti-Restenotic Agent (1998-2000)

Experts

Associate Professor Barbara Rolfe

Principal Research Fellow and Group Leader
Australian Institute for Bioengineering and Nanotechnology
Barbara Rolfe
Barbara Rolfe